antibody

Fibrinogen Antibody LS-C147773

LS-C147773

polyclonal

domestic rabbit

nonconjugated

LS-C147773

Human

Rabbit

Fibrinogen Antibody LS-C147773

Human Fibrinogen. The reactivity of the antiserum is restricted to fibrinogen. In immunoelectrophoresis and radial immunodiffusion (Ouchterlony), using various antiserum concentrations against fresh normal human plasma a single precipitin line is obtained which shows a reaction of identity with the precipitin line obtained with purified fibrinogen. No reaction is obtained with any other plasma protein component or serum. However, the antiserum may also react with fibrin monomers, circulating fibrinopeptides and fibrin degradation products. Cross-reactivity The antiserum does not cross react with any other component of human plasma. Inter-species cross- reactivity is a normal feature of antibodies to plasma proteins since they frequently share antigenic determinants. Cross-reactivity of this antiserum has not been tested in detail.

Polyclonal

Unconjugated

Lyophilized antiserum

Human Fibrinogen.

Immunoaffinity absorbed

Short term: store at 4°C. Long term: store at -20°C. Avoid freeze-thaw cycles.

Use 1 ml of sterile Distilled water.

Fibrinogen

Human

ID

Fibrinogen antibody LS-C147773 is an unconjugated rabbit polyclonal antibody to human Fibrinogen. Validated for ID.

This product is intended for use in precipitating techniques as immunoelectrophoresis and single or double radial immunodiffusion to identify the presence of fibrinogen in human plasma or other body fluids or to determine its concentration. The normal concentration of fibrinogen in the blood is 2.5 to 3.5 ml /ml, but lower levels are usually adequate for haemostasis. In newborn infants the value is 1.2 to 2.4 mg/ml. Synthesis of fetal fibrinogen may persists for up to 8 weeks, when adult levels are reached. Adult level increase with age and are a risk for heart disease, myocardial infarction and stroke. Fibrinogen is an acute Phase protein and increased levels are found in loosing enteropathies, in severe malnutrition, in tissue necrosis and in malignancy. Extremely high levels are seen in acute pancreatitis and, to a lower extent, in nephritic syndrome. A moderate raise may also been seen during pregnancy and the use of oral contraceptives. Fibrinogen deficiency may be congenital or acquired. If sufficiently severe, it may result in a bleeding disorder. The congenital form is very rare. Acquired hypofibrinogaemia is relatively common, probably indicating increased consumption during intravascular clotting.

Worldwide